NCT05563272 2025-07-10STARBURSTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 2 Terminated11 enrolled
NCT05429866 2023-03-08Immunological Variables Associated to ICI Toxicity in Cancer PatientsJules Bordet InstitutePhase 2 Unknown441 enrolled
NCT00002475 2013-07-10Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 2 Completed40 enrolled
NCT00062283 2013-06-26Alanosine in Treating Patients With CancerNational Cancer Institute (NCI)Phase 2 Completed